C. Bentzen

471 total citations
18 papers, 415 citations indexed

About

C. Bentzen is a scholar working on Surgery, Cancer Research and Molecular Biology. According to data from OpenAlex, C. Bentzen has authored 18 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 9 papers in Cancer Research and 8 papers in Molecular Biology. Recurrent topics in C. Bentzen's work include Cancer, Lipids, and Metabolism (9 papers), Lipoproteins and Cardiovascular Health (7 papers) and Cholesterol and Lipid Metabolism (6 papers). C. Bentzen is often cited by papers focused on Cancer, Lipids, and Metabolism (9 papers), Lipoproteins and Cardiovascular Health (7 papers) and Cholesterol and Lipid Metabolism (6 papers). C. Bentzen collaborates with scholars based in Switzerland, United Kingdom and United States. C. Bentzen's co-authors include Eric J. Niesor, Anne Perez, Jean Flach, Jean‐François Dufour, Olivier Maurhofer, Andrea De Gottardi, Christoph A. Maurer, Theo A. Berkhout, Peter L. Bonate and Keith E. Suckling and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

C. Bentzen

18 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Bentzen Switzerland 10 204 171 168 80 57 18 415
Lisa Borges-Marcucci Canada 8 172 0.8× 98 0.6× 85 0.5× 60 0.8× 50 0.9× 9 403
Jun-Min Zhou China 11 355 1.7× 303 1.8× 301 1.8× 61 0.8× 116 2.0× 13 781
Vincent Bertholet Belgium 10 262 1.3× 389 2.3× 66 0.4× 95 1.2× 30 0.5× 13 665
Kimiya Maeda Japan 7 76 0.4× 142 0.8× 391 2.3× 137 1.7× 70 1.2× 14 602
Quan Jiang China 15 169 0.8× 213 1.2× 43 0.3× 95 1.2× 73 1.3× 30 534
Lorell Discenza United States 8 105 0.5× 274 1.6× 81 0.5× 68 0.8× 29 0.5× 11 523
Graziella Malaponte Italy 9 125 0.6× 241 1.4× 56 0.3× 67 0.8× 47 0.8× 10 481
S. Theocharis Greece 10 97 0.5× 314 1.8× 62 0.4× 78 1.0× 19 0.3× 16 551
Birgitta Mörk Sweden 10 246 1.2× 231 1.4× 168 1.0× 50 0.6× 17 0.3× 10 470
Jean Sargent United States 13 211 1.0× 348 2.0× 36 0.2× 82 1.0× 33 0.6× 28 601

Countries citing papers authored by C. Bentzen

Since Specialization
Citations

This map shows the geographic impact of C. Bentzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Bentzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Bentzen more than expected).

Fields of papers citing papers by C. Bentzen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Bentzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Bentzen. The network helps show where C. Bentzen may publish in the future.

Co-authorship network of co-authors of C. Bentzen

This figure shows the co-authorship network connecting the top 25 collaborators of C. Bentzen. A scholar is included among the top collaborators of C. Bentzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Bentzen. C. Bentzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Edwards, Claire M., Anke J. Roelofs, Andrew Chantry, et al.. (2007). Apomine™, an inhibitor of HMG‐CoA‐reductase, promotes apoptosis of myeloma cellsin vitroand is associated with a modulation of myelomain vivo. International Journal of Cancer. 120(8). 1657–1663. 17 indexed citations
2.
Gottardi, Andrea De, Christoph A. Maurer, Anne Perez, et al.. (2004). The Bile Acid Nuclear Receptor FXR and the Bile Acid Binding Protein IBABP Are Differently Expressed in Colon Cancer. Digestive Diseases and Sciences. 49(6). 982–989. 120 indexed citations
3.
Bonate, Peter L., et al.. (2004). Population pharmacokinetics of APOMINE™: A meta‐analysis in cancer patients and healthy males. British Journal of Clinical Pharmacology. 58(2). 142–155. 19 indexed citations
4.
Vigushin, David M., Yuan-Lin Dong, Lindsey Inman, et al.. (2004). The Nuclear Oxysterol Receptor LXRα Is Expressed in the Normal Human Breast and in Breast Cancer. Medical Oncology. 21(2). 123–132. 28 indexed citations
5.
Roitelman, Joseph, Danièle Masson, Rachel Avner, et al.. (2004). Apomine, a Novel Hypocholesterolemic Agent, Accelerates Degradation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase and Stimulates Low Density Lipoprotein Receptor Activity. Journal of Biological Chemistry. 279(8). 6465–6473. 29 indexed citations
6.
7.
Alberts, David S., Alton V. Hallum, Dava J. Garcia, et al.. (2001). Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of Apomine (SR-45023A), a novel oral biphosphonate anticancer drug.. PubMed. 7(5). 1246–50. 28 indexed citations
8.
Niesor, Eric J., et al.. (2001). The Nuclear Receptors FXR and LX alpha Potential Targets for the Development of Drugs Affecting Lipid Metabolism and Neoplastic Diseases. Current Pharmaceutical Design. 7(4). 231–259. 45 indexed citations
9.
Flach, Jean, et al.. (2000). The Mevalonate/Isoprenoid Pathway Inhibitor Apomine (SR-45023A) Is Antiproliferative and Induces Apoptosis Similar to Farnesol. Biochemical and Biophysical Research Communications. 270(1). 240–246. 26 indexed citations
10.
Bentzen, C., et al.. (1997). 2.P.102 Nicotinic acid decreases specifically plasma Lp(a) in cynomolgus monkeys without affecting other lipoproteins. Atherosclerosis. 134(1-2). 137–138. 1 indexed citations
11.
Berkhout, Theo A., Dilip D. Patel, C. Bentzen, et al.. (1996). The Novel Cholesterol-lowering Drug SR-12813 Inhibits Cholesterol Synthesis via an Increased Degradation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase. Journal of Biological Chemistry. 271(24). 14376–14382. 35 indexed citations
12.
Suckling, Keith E., William Kerns, Andrew Gee, et al.. (1994). SK&F 99085/SR-9223i, a novel hypocholesterolemic agent with multiple anti-atherosclerotic properties, lowers plasma cholesterol in normocholesterolemic animals. Atherosclerosis. 109(1-2). 166–167. 2 indexed citations
13.
14.
Niesor, Eric J., Pierre Maechler, Andrew Gee, et al.. (1994). SR-9223i/SK&F 99085, a novel hypocholesterolemic agent with multiple anti-atherosclerotic properties, inhibits ACAT and lipoprotein oxidation. Atherosclerosis. 109(1-2). 167–167. 2 indexed citations
15.
16.
Maechler, Pierre, Claes B. Wollheim, C. Bentzen, & Eric J. Niesor. (1993). Importance of Exogenous Cholesterol in Diabetic Rats: Effects of Treatment with Insulin or with an Acyl-CoA:Cholesterol Acyltransferase Inhibitor. Annals of Nutrition and Metabolism. 37(4). 199–209. 4 indexed citations
17.
Niesor, Eric J., et al.. (1987). gem-Diphosphonate and gem-phosphonate-phosphate compounds with specific high density lipoprotein inducing activity. Journal of Medicinal Chemistry. 30(8). 1426–1433. 46 indexed citations
18.
Bentzen, C. & Klaus Brendel. (1979). Synthesis of [24, 25-3H]cholesterol: a new substrate for determining the rate of cholesterol side chain oxidation.. Journal of Lipid Research. 20(1). 134–139. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa Borges-Marcucci Breakdown of academic impact, for papers by Jun-Min Zhou Breakdown of academic impact, for papers by Vincent Bertholet Breakdown of academic impact, for papers by Kimiya Maeda Breakdown of academic impact, for papers by Quan Jiang Breakdown of academic impact, for papers by Lorell Discenza Breakdown of academic impact, for papers by Graziella Malaponte Breakdown of academic impact, for papers by S. Theocharis Breakdown of academic impact, for papers by Birgitta Mörk Breakdown of academic impact, for papers by Jean Sargent
Rankless by CCL
2026